AMGEN INC SG&A Expense 2007-2025 | AMGN
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is AMGEN INC's current sg&a expense?
AMGEN INC (AMGN) annual sg&a expense for 2025 was $7.05B, a 0.65% decline from 2024. AMGEN INC sg&a expense for the quarter ending December 31, 2025 was $1.95B.
What was AMGEN INC's sg&a expense in 2024?
AMGEN INC annual sg&a expense for 2024 was $7.10B, a 14.84% increase from 2023.
What was AMGEN INC's sg&a expense in 2023?
AMGEN INC annual sg&a expense for 2023 was $6.18B, a 14.13% increase from 2022.
What is AMGEN INC's 5-year sg&a expense CAGR?
AMGEN INC sg&a expense grew at a compound annual growth rate (CAGR) of 4.23% from FY2020 to FY2025, going from $5.73B to $7.05B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+4.2%
FY2020
$5.73B
→
FY2025
$7.05B
07080910111213141516171819202122232425
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.05B | -0.6% | 10-K |
| FY2024 | $7.10B | +14.8% | 10-K |
| FY2023 | $6.18B | +14.1% | 10-K |
| FY2022 | $5.41B | +0.9% | 10-K |
| FY2021 | $5.37B | -6.3% | 10-K |
| FY2020 | $5.73B | +11.3% | 10-K |
| FY2019 | $5.15B | -3.4% | 10-K |
| FY2018 | $5.33B | +9.5% | 10-K |
| FY2017 | $4.87B | -3.8% | 10-K |
| FY2016 | $5.06B | +4.5% | 10-K |
| FY2015 | $4.85B | +3.1% | 10-K |
| FY2014 | $4.70B | -9.4% | 10-K |
| FY2013 | $5.18B | +7.7% | 10-K |
| FY2012 | $4.81B | +7.0% | 10-K |
| FY2011 | $4.50B | +13.0% | 10-K |
| FY2010 | $3.98B | +4.3% | 10-K |
| FY2009 | $3.82B | +0.8% | 10-K |
| FY2008 | $3.79B | +12.7% | 10-K |
| FY2007 | $3.36B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →